19 million adults (20-79) are living with diabetes in the IDF Africa Region in 2019. This figure is estimated to increase to 47 million by 2045.
45 million adults (20-79) in the IDF Africa Region have Impaired Glucose Tolerance (IGT) which places them at high risk of developing type 2 diabetes. This figures is estimated to reach 110 million by 2045.
The IDF Africa Region has the highest percentage of undiagnosed people of all IDF regions - 60% of adults living with diabetes do not know they have it.
1 in 9 live births in the IDF Africa Region are affected by hyperglycaemia in pregnancy.
USD 9.5 billion was spent on healthcare for people with diabetes in 2019—less than 1% of the total global expenditure on diabetes.
People with diabetes are at increased risk of developing cardiovascular disease (CVD). CVD is a major cause of death and disability in people with diabetes, and a barrier to sustainable development.
In 2017, the International Diabetes Federation (IDF), in partnership with Novo Nordisk, initiated the Taking Diabetes to Heart study to assess knowledge and awareness of CVD among people with type 2 diabetes. Data was collected between September 2017 and May 2018 through an online questionnaire in 32 languages. A total of 12,695 participants from 133 countries across all seven IDF regions took part in the study. The questionnaire comprised 17 questions divided into the following sections: demographics; CVD risk knowledge; CVD risk awareness; education on CVD by health professionals; and CVD information sources.